Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011-2012

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2019 Sep 21

PMID 31538921

Citations 3

Authors

Laura A Vonnahme

Maryam B Haddad

Thomas R Navin

Affiliations

Soon will be listed here.

Abstract

To refine estimates of how many persons in the United States are candidates for treatment of latent tuberculosis, we removed from analysis persons who self-reported prior treatment on the National Health and Nutrition Examination Survey 2011-2012. We estimate that 12.6 million persons could benefit from treatment to prevent active tuberculosis.

Citing Articles

Cost-effectiveness of expanded latent TB infection testing and treatment: Lynn City, Massachusetts, USA.

Beeler Asay G, Woodruff R, Sanderson D, Fisher C, Marks S, Green V Int J Tuberc Lung Dis. 2024; 28(1):21-28.

PMID: 38178297 PMC: 11149049. DOI: 10.5588/ijtld.22.0654.

Self-reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection: 2011-2012.

Mancuso J, Miramontes R, Winston C, Horsburgh Jr C, Hill A Ann Am Thorac Soc. 2021; 18(10):1669-1676.

PMID: 33684324 PMC: 8423850. DOI: 10.1513/AnnalsATS.202009-1153OC.

Estimated Latent Tuberculosis Infection Prevalence and Tuberculosis Reactivation Rates Among Non-U.S.-Born Residents in the United States, from the 2011-2012 National Health and Nutrition Examination Survey.

Yelk Woodruff R, Hill A, Marks S, Navin T, Miramontes R J Immigr Minor Health. 2020; 23(4):806-812.

PMID: 32761297 PMC: 7862421. DOI: 10.1007/s10903-020-01065-8.

References

. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep. 2005; 54(RR-15):1-47. View

Miramontes R, Hill A, Woodruff R, Lambert L, Navin T, Castro K . Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012. PLoS One. 2015; 10(11):e0140881. PMC: 4633161. DOI: 10.1371/journal.pone.0140881. View

Chee C, KhinMar K, Gan S, Barkham T, Koh C, Shen L . Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens. Eur Respir J. 2009; 36(2):355-61. DOI: 10.1183/09031936.00151309. View

Johnson C, Dohrmann S, Burt V, Mohadjer L . National health and nutrition examination survey: sample design, 2011-2014. Vital Health Stat 2. 2015; (162):1-33. View

Pollock N, Kashino S, Napolitano D, Sloutsky A, Joshi S, Guillet J . Evaluation of the effect of treatment of latent tuberculosis infection on QuantiFERON-TB gold assay results. Infect Control Hosp Epidemiol. 2009; 30(4):392-5. PMC: 3571094. DOI: 10.1086/596606. View